Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide. A complex interplay of metabolic and physiological factors contributes to atherosclerosis development and risk of adverse cardiovascular events. Two key players in this pathogenic process are insulin resistance and atherogenic lipoproteins, particularly apolipoprotein B (ApoB)-containing particles. Understanding how these factors intersect and influence […]